December 12, 2017 1:48 AM ET

Personal Products

Company Overview of CV Sciences, Inc.

Company Overview

CV Sciences, Inc., a life science company, focuses on developing and commercializing novel therapeutics utilizing synthetic Cannabidiol (CBD). The company operates through two segments, Specialty Pharmaceutical and Consumer Product. It also manufactures, markets, and sells plant-based CBD products under PlusCBD brand for a range of market sectors, including nutraceutical, beauty care, specialty foods, and vape. The company was formerly known as CannaVEST Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was founded in 2010 and is based in Las Vegas, Nevada.

2688 South Rainbow Boulevard

Suite B

Las Vegas, NV 89146

United States

Founded in 2010

38 Employees

Phone:

866-290-2157

Fax:

619-876-4321

Key Executives for CV Sciences, Inc.

Founder, Chairman, Chief Executive Officer & President
Age: 62
Total Annual Compensation: $334.8K
Co-Founder, COO, Senior VP & Director
Age: 31
Total Annual Compensation: $222.2K
CFO & Secretary
Age: 60
Total Annual Compensation: $282.3K
Compensation as of Fiscal Year 2016.

CV Sciences, Inc. Key Developments

CV Sciences, Inc. Announces Consolidated Financial Results for the Quarter and Nine Months Ended September 30, 2017

CV Sciences, Inc. announced consolidated financial results for the quarter and nine months ended September 30, 2017. For the quarter, the company reported sales of $5,591,210 against $2,939,997 for the same period a year ago. LBITDA was $442,033 against $1,316,403 for the same period a year ago. Adjusted EBITDA was $875,076 against LBITDA of $668,426 for the same period a year ago. Net loss was $589,983 against LBITDA of $1,900,736 for the same period a year ago. For the nine months, the company reported sales of $13,437,233 against $7,850,430 for the same period a year ago. LBITDA was $4,850,967 against $4,058,356 for the same period a year ago. Adjusted EBITDA was $404,382 against LBITDA of $2,159,546 for the same period a year ago. Net loss was $5,366,946 against LBITDA of $5,660,755 for the same period a year ago.

CV Sciences, Inc., Q3 2017 Earnings Call, Nov 08, 2017

CV Sciences, Inc., Q3 2017 Earnings Call, Nov 08, 2017

CV Sciences, Inc. Presents at The MicroCap Conference-Fall 2017, Oct-05-2017 09:00 AM

CV Sciences, Inc. Presents at The MicroCap Conference-Fall 2017, Oct-05-2017 09:00 AM. Venue: The Essex House, 160 Central Park S, New York, New York, United States. Speakers: Joseph D. Dowling, CFO & Secretary.

Similar Private Companies By Industry

Company Name Region
220 Laboratories, Inc. United States
29 Luxury Goods, Inc. United States
3000BC LLC United States
310 Nutrition, LLC United States
400 Beverly, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
March 1, 2017
--
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CV Sciences, Inc., please visit www.cvsciences.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.